Overexpression of S100A14 contributes to malignant progression and predicts poor prognosis of lung adenocarcinoma.

Fang DingDi WangXu-Kun LiLin YangHui-Ying LiuWei CuiZhi-Hua LiuYi-Qun Che

Published in: Thoracic cancer (2018)

S100A14 increases the motility of lung adenocarcinoma cells, and might be a diagnostic and prognostic serum biomarker and potential therapeutic target for lung adenocarcinoma.

Keyphrases

poor prognosis
long non coding rna
induced apoptosis
transcription factor
biofilm formation
escherichia coli
cystic fibrosis